NCT04597450View on ClinicalTrials.gov

Lu AG06466 in Participants With Post Traumatic Stress Disorder (PTSD)

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

September 30, 2020

Primary Completion Date

February 13, 2023

Study Completion Date

February 13, 2023

Conditions
PTSD
Interventions
DRUG

Lu AG06466

Lu AG06466 - 30 mg/day, capsules, orally, once daily, one capsule will be taken daily for 15 days per treatment period

DRUG

Placebo

Placebo - capsules, orally, once daily, one capsule will be taken daily for 15 days per treatment period

Trial Locations (1)

90806

Collaborative NeuroScience Network LLC, Long Beach

All Listed Sponsors
lead

H. Lundbeck A/S

INDUSTRY

NCT04597450 - Lu AG06466 in Participants With Post Traumatic Stress Disorder (PTSD) | Biotech Hunter | Biotech Hunter